Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.09
- Piotroski Score 5.00
- Grade Equal-Weight
- Symbol (ACCD)
- Company Accolade, Inc.
- Price $3.68
- Changes Percentage (3.23%)
- Change $0.12
- Day Low $3.52
- Day High $3.69
- Year High $15.36
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 01/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $52.00
- Low Stock Price Target $5.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.33
- Trailing P/E Ratio -5.02
- Forward P/E Ratio -5.02
- P/E Growth -5.02
- Net Income $-99,805,000
Income Statement
Quarterly
Annual
Latest News of ACCD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Accolade Inc (ACCD) Q2 2025 Earnings Call Transcript Highlights: Strong Revenue and Cash Flow ...
Accolade projects an Adjusted EBITDA loss of $3-5 million for the third fiscal quarter. CEO Rajeev Singh highlights strong demand, bundled services, and high retention rates, emphasizing the company's...
By Yahoo! Finance | 1 month ago -
Accolade, Inc. (ACCD) Stock Price, News, Quote & History - Yahoo Finance
Accolade, Inc. reported strong financial results for Q1 ended May 31, 2024. They focus on improving healthcare access and outcomes through their physician-led advocacy approach and Healthcare AI leade...
By Yahoo! Finance | 4 months ago -
Is Accolade Inc. (ACCD) a Good Small-Cap Stock to Buy?
A compilation of the Top 10 Small-Cap Stocks with High Upside Potential includes an analysis of Accolade Inc. (NASDAQ:ACCD), highlighting its growth potential and ranking among small-cap stocks....
By Yahoo! Finance | 4 months ago
